Sulfadimethoxine structure
|
Common Name | Sulfadimethoxine | ||
---|---|---|---|---|
CAS Number | 122-11-2 | Molecular Weight | 310.329 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 548.5±60.0 °C at 760 mmHg | |
Molecular Formula | C12H14N4O4S | Melting Point | 200 °C | |
MSDS | Chinese USA | Flash Point | 285.5±32.9 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of SulfadimethoxineSulfadimethoxine is a sulfonamide antibiotic.Target: AntibacterialSulfadimethoxine is a sulfonamide antibiotic. Sulfadimethoxine is used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. Sulfadimethoxine is approved in Russia for use in humans, including children, and has been successfully used there for more than 35 years. It is widely available in Russia as an over-the-counter drug manufactured by a number of Russian pharmaceutical companies [1]. |
Name | sulfadimethoxine |
---|---|
Synonym | More Synonyms |
Description | Sulfadimethoxine is a sulfonamide antibiotic.Target: AntibacterialSulfadimethoxine is a sulfonamide antibiotic. Sulfadimethoxine is used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. Sulfadimethoxine is approved in Russia for use in humans, including children, and has been successfully used there for more than 35 years. It is widely available in Russia as an over-the-counter drug manufactured by a number of Russian pharmaceutical companies [1]. |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 548.5±60.0 °C at 760 mmHg |
Melting Point | 200 °C |
Molecular Formula | C12H14N4O4S |
Molecular Weight | 310.329 |
Flash Point | 285.5±32.9 °C |
Exact Mass | 310.073578 |
PSA | 124.81000 |
LogP | 1.48 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.623 |
Storage condition | 2-8°C |
Water Solubility | NH4OH 1 M: 50 mg/mL, clear, faintly yellow |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H317-H319-H335 |
Precautionary Statements | P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xi: Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36/37-S24/25-S23 |
RIDADR | 3249 |
WGK Germany | 3 |
RTECS | WO9030000 |
Packaging Group | III |
Hazard Class | 6.1(b) |
HS Code | 2935009090 |
~79% Sulfadimethoxine CAS#:122-11-2 |
Literature: Luk'yanov, A. V.; Onoprienko, V. S.; Borodina, K. S.; Zasosov, V. A.; Van'kovich, E. V.; et al. Pharmaceutical Chemistry Journal, 1980 , vol. 14, # 9 p. 640 - 644 Khimiko-Farmatsevticheskii Zhurnal, 1980 , vol. 14, # 9 p. 87 - 91 |
~% Sulfadimethoxine CAS#:122-11-2 |
Literature: Pharmaceutical Chemistry Journal, , vol. 14, # 9 p. 640 - 644 Khimiko-Farmatsevticheskii Zhurnal, , vol. 14, # 9 p. 87 - 91 |
~% Sulfadimethoxine CAS#:122-11-2 |
Literature: Pharmaceutical Chemistry Journal, , vol. 14, # 9 p. 640 - 644 Khimiko-Farmatsevticheskii Zhurnal, , vol. 14, # 9 p. 87 - 91 |
~% Sulfadimethoxine CAS#:122-11-2 |
Literature: Monatshefte fuer Chemie, , vol. 87, p. 136,142 |
~% Sulfadimethoxine CAS#:122-11-2 |
Literature: Monatshefte fuer Chemie, , vol. 87, p. 136,142 |
~% Sulfadimethoxine CAS#:122-11-2 |
Literature: Monatshefte fuer Chemie, , vol. 87, p. 136,142 |
~% Sulfadimethoxine CAS#:122-11-2 |
Literature: Monatshefte fuer Chemie, , vol. 87, p. 136,142 |
HS Code | 2935009090 |
---|---|
Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
Antimicrob. Agents Chemother. 54 , 5406-12, (2010) A multidrug efflux pump designated LmrS (lincomycin resistance protein of Staphylococcus aureus), belonging to the major facilitator superfamily (MFS) of transporters, was cloned, and the role of LmrS... |
|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Chem. Res. Toxicol. 23 , 171-83, (2010) Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental... |
|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins
Bioorg. Med. Chem. 17 , 896-904, (2009) This paper reports a QSAR study for predicting the complexation of a large and heterogeneous variety of substances (233 organic compounds) with beta-cyclodextrins (beta-CDs). Several different theoret... |
sulfadimethoxine |
-N-((2,6-Dimethoxy-4-pyrimidinyl)sulfanilamide (8CI) |
T6N CNJ BO1 DO1 FMSWR DZ |
MFCD00057345 |
4-Amino-N-(2,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide |
4-Amino-N-[2,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide |
4-amino-N-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide |
Benzenesulfonamide, 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)- |
EINECS 204-523-7 |
sulphadimethoxine |